Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
562,437,210
-
Share change
-
-3,146,758
-
Total reported value
-
$6,653,059,125
-
Put/Call ratio
-
129%
-
Price per share
-
$11.83
-
Number of holders
-
311
-
Value change
-
-$34,627,484
-
Number of buys
-
138
-
Number of sells
-
143
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q4 2024
As of 31 Dec 2024,
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) was held by
311 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
562,437,210 shares.
The largest 10 holders included
QVT Financial LP, SB INVESTMENT ADVISERS (UK) LTD, FMR LLC, VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, BlackRock, Inc., MORGAN STANLEY, STATE STREET CORP, Rubric Capital Management LP, and Patient Square Capital LP.
This page lists
314
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.